Fexofenadine
Sold as Telfast, Fexaway, Fastway, Tellerge, * fexofenadine unicorn, Sensafex, Obihist, Fexxtab, Fexohet, Fexofenadine clicks, Fexofenadine kiara, Fexofenadine pharma-q, Fenoaleji, Fenohist, Fenofex, Fexo, Cipla-fexofenadine hydrochloride, Fexogen, Pollofex
2-[4-[1-Hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid
Drag to rotate. Structure from PubChem CID 3348.
Background
Registration
- Applicants
- 16
- Registrations
- 38
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Opella Healthcare South Africa (Pty) LtdCertificate held by Sanofi-aventis South Africa (Pty) Ltd | Telfast | 120, 180 mg, suspension | 320446, 320447, 420339 | S1 | PIPIL |
| Adcock ingram limited | Fexaway, Tellerge | 120 mg, 180 mg | 410133, 410134, 410352, 410353 | S1 | None |
| Dr Reddyæs Laboratories (Pty) Ltd | Fastway | 120, 180 | 410319, 410320 | S1 | None |
| Unicorn Pharmaceuticals (Pty) Ltd | * fexofenadine unicorn, Fexofenadine clicks | 120 mg, 180 mg | 470975, 470976, 560779, 560780 | S1 | None |
| Oethmaan Biosims (Pty) Ltd | Sensafex, Obihist | 120 mg, 180 mg | 470977, 470978, 480448, 480449 | S1 | PIPIL |
| Activo Health (Pty) LtdCertificate held by Forrester Pharma (Pty) Ltd | Fexxtab | 120, 180 | 500726, 500727 | S1 | PIPIL |
| Hetero Drugs South Africa (Pty) Ltd | Fexohet | 120, 180 | 520008, 520009 | S1 | None |
| Kiara Health (Pty) Ltd | Fexofenadine kiara | 120, 180 | 560859, 560860 | S1 | None |
| Pharma-q Holdings (Pty) Ltd | Fexofenadine pharma-q | 120, 180 | 570459, 570460 | S1 | None |
| Pharmacorp (Pty) Ltd | Fenoaleji | Not stated | 590031 | S1 | None |
| Unimed Healthcare (Pty) Ltd | Fenohist | 120, 180 | A380400, A380401 | S1 | None |
| Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd | Fenofex | 120 | A380407 | S1 | PIPIL |
| Ranbaxy (SA) (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd | Fenofex | 180 | A380408 | S1 | PIPIL |
| Cipla Medpro (Pty) LtdCertificate held by Cipla Medpro (Pty) Ltd.2 of 4 cancelled | Fexo, Cipla-fexofenadine hydrochloride | 120, 180 | A380414, A380415, A380423, A380424 | S1 | PIPIL |
| Trinity Pharma (Pty) Ltd | Fexogen | 120mg/180mg | A400083, A400084 | S1 | PIPIL |
| Biotech Laboratories (Pty) Ltd | Pollofex | 120, 180 | A400590, A400591 | S1 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Telfast 120 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120 | 32044632/5.7.1/0446 | Registered | S1 | None |
| Telfast 180 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 180 mg | 180 mgTablets | 32044732/5.7.1/0447Approved 11 May 2022 | Registered | S1 | PIPIL |
| Fexaway 120 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE EQUIVALENT TO FEXOFENADINE 120,0 mg | 120 | 41013341/5.7.1/0133 | Registered | S1 | None |
| Fexaway 180 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE EQUIVALENT TO FEXOFENADINE 180,0 mg | 180 | 41013441/5.7.1/0134 | Registered | S1 | None |
| Fastway 120 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE EQUIVALENT TO FEXOFENADINE 120,0 mg | 120 | 41031941/5.7.1/0319 | Registered | S1 | None |
| Fastway 180 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE EQUIVALENT TO FEXOFENADINE 180,0 mg | 180 | 41032041/5.7.1/0320 | Registered | S1 | None |
| Tellerge 120 MG EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE EQUIVALENT TO FEXOFENADINE 120,0 mg | 120 mg | 41035241/5.7.1/0352 | Registered | S1 | None |
| Tellerge 180 MG EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE EQUIVALENT TO FEXOFENADINE 180,0 mg | 180 mg | 41035341/5.7.1/0353 | Registered | S1 | None |
| Telfast suspension EACH 5,0 ml SUSPENSION CONTAINS FEXOFENADINE HYDROCHLORIDE 30,0 mg | Suspension | 42033942/5.7.1/0339 | Registered | S1 | None |
| * fexofenadine 120 MG unicorn Each tablet contains FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120 mg | 47097547/5.7.1/0975 | Registered | S1 | None |
| * fexofenadine 180 MG unicorn Each tablet contains FEXOFENADINE HYDROCHLORIDE 180,0 mg | 180 mg | 47097647/5.7.1/0976 | Registered | S1 | None |
| Sensafex 120 MG Each tablet contains FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120 mgFilm-coated tablets | 47097747/5.7.1/0977Approved 3 September 2024 | Registered | S1 | PIPIL |
| Sensafex 180 MG Each tablet contains FEXOFENADINE HYDROCHLORIDE 180,0 mg | 180 mgFilm-coated tablets | 47097847/5.7.1/0978Approved 3 September 2024 | Registered | S1 | PIPIL |
| Obihist 120 MG Each tablet contains FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120 mgFilm-coated tablets | 48044848/5.7.1/0448Approved 3 September 2024 | Registered | S1 | PIPIL |
| Obihist 180 MG Each tablet contains FEXOFENADINE HYDROCHLORIDE 180,0 mg | 180 mgFilm-coated tablets | 48044948/5.7.1/0449Approved 3 September 2024 | Registered | S1 | PIPIL |
| Fexxtab 120 Each tablet contains FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120Film-coated tablets | 50072650/5.7.1/0726Approved 20 June 2024 | Registered | S1 | PIPIL |
| Fexxtab 180 Each tablet contains FEXOFENADINE HYDROCHLORIDE 180,0 mg | 180Film-coated tablets | 50072750/5.7.1/0727Approved 20 June 2024 | Registered | S1 | PIPIL |
| Fexohet 120 EACH TABLET CONTAINS: FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120 | 52000852/5.7.1/0008 | Registered | S1 | None |
| Fexohet 180 EACH TABLET CONTAINS: FEXOFENADINE HYDROCHLORIDE 180,0 mg | 180 | 52000952/5.7.1/0009 | Registered | S1 | None |
| Fexofenadine 120 MG clicks EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120 mg | 56077956/5.7.1/0779 | Registered | S1 | None |
| Fexofenadine 180 MG clicks EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 180,0 mg | 180 mg | 56078056/5.7.1/0780 | Registered | S1 | None |
| Fexofenadine 120 kiara EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120 | 56085956/5.7.1/0859 | Registered | S1 | None |
| Fexofenadine 180 kiara EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 180,0 mg | 180 | 56086056/5.7.1/0860 | Registered | S1 | None |
| Fexofenadine 120 pharma-q EACH TABLET CONTAINS: FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120 | 57045957/5.7.1/0459 | Registered | S1 | None |
| Fexofenadine 180 pharma-q EACH TABLET CONTAINS: FEXOFENADINE HYDROCHLORIDE 180,0 mg | 180 | 57046057/5.7.1/0460 | Registered | S1 | None |
| Fenoaleji EACH TABLET CONTAINS: FEXOFENADINE HYDROCHLORIDE 180,0 mg | Not listed | 59003159/5.7.1/0031 | Registered | S1 | None |
| Fenohist 120 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120 | A380400A38/5.7.1/0400 | Registered | S1 | None |
| Fenohist 180 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 180,0 mg | 180 | A380401A38/5.7.1/0401 | Registered | S1 | None |
| Fenofex 120 EACH TABLET CONTAINS: FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120Film coated tablet | A380407A38/5.7.1/0407Approved 8 August 2022 | Registered | S1 | PIPIL |
| Fenofex 180 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 180,0 mg | 180Film coated tablet | A380408A38/5.7.1/0408Approved 8 August 2022 | Registered | S1 | PIPIL |
| Fexo 120 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120Film-coated tablets. | A380414A38/5.7.1/0414Approved 15 May 2025 | Registered | S1 | PIPIL |
| Fexo 180 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 180,0 mg | 180Film-coated tablets. | A380415A38/5.7.1/0415Approved 15 May 2025 | Registered | S1 | PIPIL |
| Cipla-fexofenadine hydrochloride 120 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120 | A380423A38/5.7.1/0423 | Cancelled | S1 | None |
| Cipla-fexofenadine hydrochloride 180 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 180,0 mg | 180 | A380424A38/5.7.1/0424 | Cancelled | S1 | None |
| Fexogen 120 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120mg/180mgFilm-coated tablets | A400083A40/5.7.1/0083Approved 20 March 2026 | Registered | S1 | PIPIL |
| Fexogen 180 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 180,0 mg | 120mg/180mgFilm-coated tablets | A400084A40/5.7.1/0084Approved 20 March 2026 | Registered | S1 | PIPIL |
| Pollofex 120 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 120,0 mg | 120Film-coated tablets | A400590A40/5.7.1/0590Approved 29 November 2023 | Registered | S1 | PIPIL |
| Pollofex 180 EACH TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE 180,0 mg | 180Film-coated tablets | A400591A40/5.7.1/0591Approved 29 November 2023 | Registered | S1 | PIPIL |
Regulatory status
Where S1 sits on the scale
Sold by a pharmacist, no doctor's prescription needed.
Schedule 1 medicines are normally sold by a pharmacist, or by a supervised pharmacist intern or assistant, without a doctor's visit; a veterinarian, or a licensed dispensing doctor, dentist or nurse prescriber, may also supply them. A nurse or other non-doctor prescriber may only prescribe the specific substances the Schedule names for that purpose, and may only dispense them if licensed to do so. A child under 12 may only be sold one of these medicines on a prescription, or on a written order that names the purpose and carries a signature the seller recognises.
Schedule S1, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist, or a supervised pharmacist intern or assistant; manufacturers and wholesalers supplying people who may lawfully possess it; a veterinarian, who may prescribe, compound or dispense it; a medical practitioner or dentist, who may prescribe it, and may compound or dispense it only if licensed under section 22C(1)(a); a nurse or other registered non-doctor prescriber, who may prescribe only the Scheduled substances the Schedule identifies for that purpose, and dispense them if licensed to do so; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Fexofenadine hydrochloride
S1: Fexofenadine
Consolidated Schedules 06 July 2026, line 439
Pharmacological class: Antihistaminics. (class 5.7.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Telfast 180, Opella Healthcare South Africa (Pty) Ltd is scheduled S1 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.